Test-retest variability of [¹¹C]raclopride-binding potential in nontreatment-seeking alcoholics.

scientific article

Test-retest variability of [¹¹C]raclopride-binding potential in nontreatment-seeking alcoholics. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/SYN.20874
P932PMC publication ID3077540
P698PubMed publication ID20963816
P5875ResearchGate publication ID227850077

P50authorChristine HerringQ79370072
Karmen K. YoderQ87217774
P2093author name stringDavid A Kareken
Daniel S Albrecht
Qi-Huang Zheng
Sean O'Connor
Lauren M Federici
Bruce H Mock
Elizabeth A Patton
Kevin M Perry
P2860cites workIntraclass correlations: uses in assessing rater reliabilityQ28296226
Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbensQ33865234
Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical reviewQ33867444
When what you see isn't what you get: alcohol cues, alcohol administration, prediction error, and human striatal dopamineQ34002723
Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brainQ34230368
A 18F-MPPF PET normative database of 5-HT1A receptor binding in men and women over agingQ34473208
Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).Q34476552
Consensus nomenclature for in vivo imaging of reversibly binding radioligandsQ34630958
Smoking and drinking as complementary behavioursQ35679101
What were they thinking? Cognitive states may influence [11C]raclopride binding potential in the striatumQ36512815
Distribution volume ratios without blood sampling from graphical analysis of PET dataQ36817029
The dopaminergic basis of human behaviors: A review of molecular imaging studiesQ37500893
Development and initial validation of a measure of drinking urges in abstinent alcoholicsQ39474611
Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's diseaseQ40298357
A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA.Q40755655
Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatumQ43721371
Different striatal dopamine D2 receptor occupancy in alcohol dependent patients with or without physical withdrawal symptoms --a study using IBZM-SPECT.Q44119478
Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: a preliminary studyQ44245935
Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatumQ44351037
Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-racloprideQ44662170
Smoking-induced ventral striatum dopamine releaseQ44960116
Effects of endogenous dopamine on kinetics of [3H]N-methylspiperone and [3H]raclopride binding in the rat brainQ45068213
Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brainQ45248583
Smoking comorbidity in alcoholism: neurobiological and neurocognitive consequences.Q46234820
A self-administered questionnaire to measure cigarette withdrawal symptoms: the Cigarette Withdrawal Scale.Q46417087
Alcohol dependence is associated with blunted dopamine transmission in the ventral striatumQ46600038
Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent ratsQ46694717
Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvementQ46899798
Heterogeneous effects of alcohol on dopamine release in the striatum: a PET studyQ48207687
Measurement of striatal D2 dopamine receptor density and affinity with [11C]-raclopride in vivo: a test-retest analysisQ48278378
Reproducibility of repeated measures of carbon-11-raclopride binding in the human brainQ48312214
Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine cravingQ48421523
Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET studyQ48481156
Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction.Q48496653
Long-term stability of neurotransmitter activity investigated with 11C-raclopride PET.Q48574625
Decreases in dopamine receptors but not in dopamine transporters in alcoholicsQ48846413
Comparison of direct interview and family history diagnoses of alcohol dependence.Q52335246
Forming inferences about some intraclass correlation coefficientsQ56852924
A validity study of the SSAGA--a comparison with the SCANQ73312734
Clamping breath alcohol concentration reduces experimental variance: application to the study of acute tolerance to alcohol and alcohol elimination rateQ74351087
A physiologically-based pharmacokinetic (PBPK) model for alcohol facilitates rapid BrAC clampingQ77424512
Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivityQ93516349
P433issue7
P304page(s)553-561
P577publication date2010-12-08
P1433published inSynapseQ7662025
P1476titleTest-retest variability of [¹¹C]raclopride-binding potential in nontreatment-seeking alcoholics
P478volume65

Reverse relations

cites work (P2860)
Q50192659Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis
Q37357494Differences in IV alcohol-induced dopamine release in the ventral striatum of social drinkers and nontreatment-seeking alcoholics
Q53433634Differences in White Matter Microstructure and Connectivity in Nontreatment-Seeking Individuals with Alcohol Use Disorder.
Q52983670Dual time-point imaging for post-dose binding potential estimation applied to a [11C]raclopride PET dose occupancy study.
Q37281925Effects of smoking on D₂/D₃ striatal receptor availability in alcoholics and social drinkers
Q90042243High long-term test-retest reliability for extrastriatal 11C-raclopride binding in healthy older adults
Q38165911In search of biomarkers in psychiatry: EEG-based measures of brain function
Q37087243Influence of TSPO genotype on 11C-PBR28 standardized uptake values
Q40730465Levodopa effects on [ (11)C]raclopride binding in the resting human brain
Q36769232Limitations of SRTM, Logan graphical method, and equilibrium analysis for measuring transient dopamine release with [(11)C]raclopride PET.
Q48150161MP2RAGE for deep gray matter measurement of the brain: A comparative study with MPRAGE.
Q89686131Maturation of the human striatal dopamine system revealed by PET and quantitative MRI
Q35580378Reliability of striatal [¹¹C]raclopride binding in smokers wearing transdermal nicotine patches
Q36496045Striatal D(2)/D(3) receptor availability is inversely correlated with cannabis consumption in chronic marijuana users.
Q39717392Striatal dopamine transporter availability in unmedicated bipolar disorder
Q89704389Test-retest variability of brain morphometry analysis: an investigation of sequence and coil effects
Q30912675Voxel-based morphometry at ultra-high fields. a comparison of 7T and 3T MRI data
Q53440586[18F]fallypride-PET/CT Analysis of the Dopamine D₂/D₃ Receptor in the Hemiparkinsonian Rat Brain Following Intrastriatal Botulinum Neurotoxin A Injection.

Search more.